Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2Gynecologic 2Gastrointestinal 2Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia 12Breast Neoplasms 11Leukemia, Myeloid, Acute 9Congenital Abnormalities 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Myeloproliferative Disorders 7Multiple Myeloma 7Lymphoma, Mantle-Cell 7Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Waldenstrom Macroglobulinemia 5Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Colorectal Neoplasms 5Colonic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Burkitt Lymphoma 5Squamous Cell Carcinoma of Head and Neck 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma 4Lung Neoplasms 4Leukemia, Myeloid, Accelerated Phase 4Head and Neck Neoplasms 4Central Nervous System Neoplasms 4Blast Crisis 4Sezary Syndrome 3

Interventions

Gemcitabine 685130-nm albumin-bound paclitaxel 199Fluorouracil 190Oxaliplatin 177Albumin-Bound Paclitaxel 154Capecitabine 137Leucovorin 133Irinotecan 114Radiotherapy 96Taxes 85pembrolizumab 81Cisplatin 73Erlotinib Hydrochloride 70Radiosurgery 69Nivolumab 56Drug Therapy 56Bevacizumab 54Magnetic Resonance Spectroscopy 51Cyclophosphamide 50folfirinox 45Specimen Handling 43Docetaxel 42Cetuximab 40Biopsy 39irinotecan sucrosofate 38S 1 (combination) 36Pancreaticoduodenectomy 35Blood Specimen Collection 34Surgical Procedures, Operative 31Paclitaxel 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × In Situ Hybridization, Fluorescence × Clear all
NCT07403630 2026-02-17

IT-TCP POS

Azienda Ospedaliero-Universitaria di Parma

Phase NA Recruiting
300 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Carcinoma, Squamous Cell, Melanoma, Multiple Myeloma, Myeloproliferative Disorders, Ovarian Neoplasms, Pancreatic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00900094 2012-02-07

IRB 2000-294

University of Michigan Rogel Cancer Center

Completed
200 enrolled
BreastGastrointestinalGynecologicThoracic

Adenocarcinoma Of Esophagus, Carcinoma, Ovarian Epithelial, Esophageal Squamous Cell Carcinoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡